spacer
home > ebr > summer 2019 > the dna of a new industry
PUBLICATIONS
European Biopharmaceutical Review

The DNA of a New Industry

Advancements in science, combined with new and affordable technology, have created a fertile ground for biotechnology entrepreneurs. 23andMe launched the first direct-to-consumer (DTC) genomics test back in 2007. The initial price tag was US $1,000, but this was to go down very rapidly. In the next few years, 23andMe experimented with different business and pricing models, including subscription.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Efi Binder is a serial entrepreneur in the field of biotechnology and the co-founder and CEO of Israel’s first DTC genomics company, Futura Genetics. Before becoming the CEO of Futura Genetics, he co-founded Mosteq, a company developing novel biological control methods for deadly mosquitoes. Efi was also on the founding team of primal data, a facilitator of data transfer for medical research use. Before venturing on his entrepreneurial career, he spent three years working as a management consultant for top tier firms, helping big corporates define their long-term strategy. Efi is a Hebrew University, Israel, alumni with a BA in economics and an MBA.
spacer
Efi Binder
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Prince Helps Sustainable Pharma Packaging Pioneers Woolcool Celebrate 10th Anniversary

Ground-breaking sustainable pharma packaging firm Woolcool celebrated a decade of innovation with a visit by HRH The Prince of Wales.
More info >>

White Papers

Clinical Research in Spain

BioClever

This whitepaper is on clinical research in Spain, giving a general outline of the main characteristics of research in this country and an overview of the applicable regulations, along with the reasons why Spain is a good place to do research.
More info >>

 
Industry Events

World Vaccine Congress Europe

28-31 October 2019, Barcelona, Spain

The 20th annual World Vaccine Congress Europe is taking place 28-31 Oct in Barcelona. It’s the biggest and most established European vaccine event with over 250 speakers, 700+ senior vaccine attendees, hundreds of networking hours. It cover key topics across the complete vaccine value chain bringing together: • Government • big pharma • big biotech • SME Biotech • academia and the wider service provider community and their partners to discuss scientific, clinical and strategic advances and opportunities. The event has already confirmed over 200 speakers from Human Vaccine Project, OECD, CEPI, European Commission, FDA, WHO, OECD, NIH, GSK and many more… There is a Super Early Bird offer available – Find Out More www.terrapinn.com/WVCEU/EBR
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement